Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs zoledronic acid in Asian patients with solid tumor bone metastases
CTR20130101Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in bone metastases, Non-hematologic malignancy, sponsored by Amgen. Started Apr 2014; status: completed.
02
Drugs
denosumab
03
Conditions
bone metastasesNon-hematologic malignancy
Beyond the preview
Go deeper on CTR20130101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130101.